The business expenditure on R&D in human health activities in Italy is expected to show a consistent growth trend from 2024 to 2028. The forecast indicates an increase in Euros per capita from 5.72 in 2024 to 6.96 in 2028, marking a steady annual increase. The year-on-year growth rates are approximately 5.59%, 5.13%, 4.72%, and 4.66% from 2024 to 2028, respectively. The compound annual growth rate (CAGR) over this period is anticipated to be around 5.27%.
Future trends to watch for include:
- Increased emphasis on digital health technologies, potentially driving further investment.
- Impact of regulatory changes on R&D spending patterns.
- Collaborations and partnerships that may lead to shared R&D efforts and innovations.